The global shift towards personalized products and sustainable resource management is intensifying demand for intelligent materials. In healthcare, stringent regulations for drug efficacy and reduced side effects drive innovation in targeted delivery. Consumer demand for high-performance, eco-friendly products pushes cosmetic and agricultural sectors towards precise ingredient control. This technology offers a critical enabler for industries to meet these evolving market and regulatory pressures, fostering innovation in smart materials and resource optimization.
Precisely control the timing and quantity of chemical species release by applying external forces (compression, tension, shear) to MOFs embedded in a polymer gel. This enables on-demand, localized substance delivery, difficult with conventional temperature or pH-responsive systems.
Leverages a highly unique approach with only 3 prior art documents, indicating a significant competitive advantage. This enables early market capture in a blue ocean space and establishes strong barriers to entry, positioning licensees to lead the market.
Encapsulates various chemical species (gases, pharmaceuticals, functional molecules) and offers a wide selection of polymer gels, enabling diverse applications across medical, cosmetics, environmental, and food industries. This versatility addresses multiple market needs with a single technology.
This patent protects a method for releasing chemical species from MOFs embedded in polymer gels via external mechanical force, along with the polymer gel and its manufacturing method. It underwent rigorous examination, overcoming two office actions, which indicates strong validity and a robust claim set. With only three prior art documents, the technology demonstrates significant uniqueness, providing a strong barrier to entry against competitors.
This patent does not cover the synthesis of novel MOF structures or the development of specific external force application devices. Licensees could innovate in these areas, such as designing new MOF architectures for specific chemical species or creating advanced micro-actuators for highly localized release.
Applying this technology to Drug Delivery Systems (DDS) could optimize drug costs through precise release control, maximizing efficacy and minimizing waste. For a pharmaceutical company using ~$6.5M (AI est.) in drugs annually, a 30% reduction in drug waste could yield ~$2.0M (AI est.) in annual cost optimization. This is calculated as direct drug cost savings, separate from enhanced treatment outcomes or reduced side effects.
X: Precise Release Control
Y: Material Compositing Flexibility